Fulgent Genetics (FLGT) Net Shares Issued and Repurchased (2015 - 2025)

Fulgent Genetics has disclosed Net Shares Issued and Repurchased across 11 years of filings, most recently posting $90000.0 for Q4 2025.

• In Q4 2025, Net Shares Issued and Repurchased fell 36.62% year-over-year to $90000.0; the TTM figure through Dec 2025 stood at $90000.0 (down 36.62% YoY), while the FY2025 annual figure was $90000.0, down 36.62% from the prior year.
• Net Shares Issued and Repurchased came in at $90000.0 for Q4 2025 at Fulgent Genetics, down from $142000.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $208000.0 in Q4 2023 to a low of $90000.0 in Q4 2025.
• Average Net Shares Issued and Repurchased over 5 years is $146200.0, with a median of $142000.0 recorded in 2024.
• Year-over-year, Net Shares Issued and Repurchased jumped 71.96% in 2022 and plunged 36.62% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $107000.0 in 2021, then jumped by 71.96% to $184000.0 in 2022, then advanced by 13.04% to $208000.0 in 2023, then tumbled by 31.73% to $142000.0 in 2024, then plunged by 36.62% to $90000.0 in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $90000.0 in Q4 2025, $142000.0 in Q4 2024, and $208000.0 in Q4 2023.